Papers
2
Total Citations
27
H-Index
2
About
Fengtong Li is a clinical researcher whose work centers on refining surgical and radiotherapeutic strategies in oncology, with a particular focus on gynecologic cancers and cerebral metastases. Li’s major contributions include challenging the routine use of lymph node dissection in early-stage endometrial cancer, a practice long considered standard. In a 2020 retrospective study (14 citations), Li demonstrated that the survival benefit of this invasive procedure may be overstated, advocating for more selective, risk-based approaches that could spare patients unnecessary morbidity. This work has helped shift clinical thinking toward personalized surgical decision-making. In the domain of neuro-oncology, Li investigated the efficacy of repeat stereotactic radiosurgery for cerebral metastases, showing in a 2018 study (13 citations) that a second course of image-guided robotic radiosurgery can be both safe and effective—offering a critical salvage option for patients with recurrent brain lesions. Though early in their career, Li’s research is already informing practice guidelines and sparking debate on de-escalation of aggressive treatments. Their work reflects a commitment to evidence-based, patient-centered care that balances oncologic control with quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2